Monitor for continued insider selling in coming weeks; while the cluster is small, insider activity at earnings time often signals near-term profit-taking. The positive launch data supports the stock, but further sales from executives could weigh on sentiment.
CYTK drugs
CYTK drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 6 $74.84entry
- T+1 · 6mo ago −0.73%α −0.43% · $74.29
- T+5 · 6mo ago +3.18%α +2.02% · $77.22
- T+20 · 6mo ago −3.41%α −6.58% · $72.29
- T+60 · 4mo ago +2.15%α −1.10% · $76.45
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Multiple CYTK insiders, including CFO and CCO, sold shares totaling $4.53M on the same day as Q1 2026 earnings release showing strong MYQORZO launch. The cluster is small relative to market cap (0.055%) but notable for involving key executives and timing with positive news.
Key Financial Metrics
Key Facts
- 4 insiders sold shares on May 5, 2026, including CFO Lee Sung ($1.84M) and CCO Andrew Callos ($875K)
- Total open-market sales: $4.53M, representing 0.055% of $8.2B market cap
- Sales occurred on same day as Q1 earnings: MYQORZO launch revenue $4.8M, ACACIA-HCM trial positive
- Directors Henderson and Wierenga also sold shares alongside derivative exercises
Financial Impact
Insiders sold $4.53M in open-market transactions, ~0.055% of market cap
Risk Factors
- Further insider selling could dampen investor sentiment
- Commercial execution of MYQORZO launch may face headwinds
- Regulatory or safety issues with aficamten in nHCM
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CYTK-1778012475448 |
Track record
46 reports on CYTK
7 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +8.59% at T+20 after the Sep 15, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $53.76 Now $56.13 +4.41% settles Dec 15
- Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $56.13 Now $56.13 +0.00% settles Dec 14
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $56.18 Now $56.13 −0.09% settles Dec 9
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $56.18 Now $56.13 −0.09% settles Dec 9
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $55.14 Now $56.13 +1.80% settles Dec 8
- Nov 9, 20267d ago Press Release Neutral 4/10 Entry $55.14 Now $56.13 +1.80% settles Dec 8
- Nov 4, 202612d ago 8-K Bullish 6/10 No price data
- Nov 4, 202612d ago Press Release Neutral 5/10 Entry $55.55 Now $56.13 +1.04% settles Dec 4
- Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $63.60 Now $56.13 −11.75% settles Dec 3
- Nov 2, 202614d ago Press Release Neutral 3/10 Entry $62.03 Now $56.13 −9.51% settles Dec 1
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers